MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

CANNAPHARMARX, INC. (CPMD)

CANNAPHARMARX, INC. (CPMD)

|||

Balance Sheets Overview

Current Ratio
4.09%
Quick Ratio
0.08%
Debt to Asset Ratio
547.34%
Unit: Dollar
Assets Breakdown
    • Right-of-use building, net
    • Inventory
    • Equipment, net
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Loans payable to related parties...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
555
633
1,804
927
Goods and services tax receivable
19,344
19,064
29,832
17,628
Accounts receivable
6,811
6,944
164,430
588,393
Inventory
1,306,302
902,913
1,115,322
863,807
Total current assets
1,333,012
929,554
1,311,388
1,470,755
Equipment, net
200,461
176,101
127,029
123,333
Right-of-use building, net
5,358,469
5,475,079
5,579,987
5,504,692
Investments
-
-
0
4,518,127
Total assets
6,891,942
6,580,734
7,018,404
11,616,907
Accounts payable and accrued liabilities
10,476,912
10,232,578
10,059,415
10,189,279
Accrued interest
2,193,967
2,157,329
1,720,278
-
Deferred revenue
36,242
0
260,561
-
Accrued interest
-
-
-
1,522,539
Notes payable
423,345
478,270
482,661
478,604
Convertible notes
1,017,004
1,017,004
1,017,004
1,017,003
Derivative conversion feature
2,808,176
1,208,438
2,009,476
556,755
Loans payable to related parties, current portion
13,075,235
13,130,027
12,567,911
11,885,572
Royalty payable
483,554
429,520
305,492
287,035
Liability for right-of-use building, current portion
964,994
983,755
1,000,479
985,027
Obligation to issue shares
1,090,155
1,849,155
2,166,681
1,558,710
Total current liabilities
32,569,584
31,486,076
31,589,958
28,480,524
Loans payable to related parties
335,144
433,696
548,574
679,397
Liability for right-of-use building
4,817,775
4,930,850
5,033,601
4,973,729
Total liabilities
37,722,503
36,850,622
37,172,133
34,133,650
Preferred stock value-Series APreferred Stock
74,416
74,416
74,416
74,416
Preferred stock, value-Series DPreferred Stock
-
-
-
455,000
Preferred stock value-Series BPreferred Stocks
-
455,000
455,000
-
Preferred stock value-Series BPreferred Stock
455,000
-
-
-
Preferred stock value-Series CPreferred Stock
100,000
100,000
100,000
100,000
Common shares, 0.0001 par value 5,000,000,000 and 5,000,000,000 shares authorized, 708,689,905 and 662,501,405 issued and outstanding as at june 30, 2026 and december 31, 2025, respectively
70,869
67,850
66,250
66,250
Shares to be issued
0
0
1,600
-
Treasury shares, 0.0001 par value 6,230,761 shares as at september 30, 2025 and december 31, 2024
-
-
-
623
Treasury shares, 0.0001 par value 6,230,761 shares as at march 31, 2026 and december 31, 2025
-
623
623
-
Treasury shares, 0.0001 par value 6,230,761 shares as at june 30, 2026 and december 31, 2025
623
-
-
-
Additional paid-in capital
82,547,535
81,520,643
81,520,643
81,379,443
Accumulated deficit
-114,606,653
-112,697,611
-112,315,590
-104,766,005
Accumulated other comprehensive income (loss)
527,649
209,191
-56,671
173,530
Total shareholders deficit
-30,830,561
-30,269,888
-30,153,729
-22,516,743
Total liabilities and shareholders deficit
6,891,942
6,580,734
7,018,404
11,616,907
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Inventory$1,306,302 (25.18%↑ Y/Y)Goods and services taxreceivable$19,344 (-16.64%↓ Y/Y)Accounts receivable$6,811 (-94.04%↓ Y/Y)Cash$555 (-96.73%↓ Y/Y)Right-of-use building, net$5,358,469 (-4.78%↓ Y/Y)Total current assets$1,333,012 (11.27%↑ Y/Y)Equipment, net$200,461 (54.93%↑ Y/Y)Total assets$6,891,942 (-39.93%↓ Y/Y)Accumulated deficit-$114,606,653 (-10.96%↓ Y/Y)Total liabilities andshareholders deficit$6,891,942 (-39.93%↓ Y/Y)Total shareholdersdeficit-$30,830,561 (-36.58%↓ Y/Y)Additional paid-in capital$82,547,535 (3.03%↑ Y/Y)Accumulated othercomprehensive income (loss)$527,649 (603.63%↑ Y/Y)Preferred stockvalue-Series BPreferred...$455,000 (0.00%↑ Y/Y)Preferred stockvalue-Series CPreferred...$100,000 (0.00%↑ Y/Y)Preferred stockvalue-Series APreferred...$74,416 (0.00%↑ Y/Y)Common shares, 0.0001par value...$70,869 (6.97%↑ Y/Y)Treasury shares, 0.0001par value 6,230,761...$623 Total liabilities$37,722,503 (10.80%↑ Y/Y)Total currentliabilities$32,569,584 (12.49%↑ Y/Y)Liability forright-of-use building$4,817,775 (-5.40%↓ Y/Y)Loans payable torelated parties$335,144 (-96.63%↓ Y/Y)Loans payable torelated parties,...$13,075,235 Accounts payable andaccrued liabilities$10,476,912 (91.96%↑ Y/Y)Derivative conversionfeature$2,808,176 (397.86%↑ Y/Y)Accrued interest$2,193,967 (-43.24%↓ Y/Y)Obligation to issue shares$1,090,155 (-36.88%↓ Y/Y)Convertible notes$1,017,004 (-21.66%↓ Y/Y)Liability forright-of-use building,...$964,994 (-3.99%↓ Y/Y)Royalty payable$483,554 (757.29%↑ Y/Y)Notes payable$423,345 (-12.51%↓ Y/Y)Deferred revenue$36,242